{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T18:12:41Z","timestamp":1692555161076},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1002\/jps.1055","type":"journal-article","created":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T21:57:15Z","timestamp":1048888635000},"page":"1026-1033","source":"Crossref","is-referenced-by-count":4,"title":["Design, in vitro stability, and ocular hypotensive activity of t-butalone chemical delivery systems"],"prefix":"10.1016","volume":"90","author":[{"given":"Indra K.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva R.","family":"Vaithiyalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Bodor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.1055_bb0010","series-title":"Ophthalmic Drug Delivery Systems","first-page":"59","article-title":"Precorneal, corneal, and postcorneal factors","author":"Lee","year":"1993"},{"issue":"7","key":"10.1002\/jps.1055_bb0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1440-1681.2000.03288.x","article-title":"Biopharmaceutical considerations in topical ocular drug delivery","volume":"27","author":"Davies","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1002\/jps.1055_bb0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0169-409X(94)90043-4","article-title":"Novel approaches to design and deliver safe and effective anti-glaucoma agents to the eye","volume":"14","author":"Reddy","year":"1994","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.1055_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jop.1994.10.3","article-title":"Designing safer ophthalmic drugs by soft drug approaches","volume":"10","author":"Bodor","year":"1994","journal-title":"J Ocular Pharmacol"},{"key":"10.1002\/jps.1055_bb0030","series-title":"Ocular Therapeutics and Drug Delivery: A Multi-Disciplinary Approach","first-page":"335","article-title":"The use of retrometabolic drug design concepts in ophthalmic drug discovery","author":"Bodor","year":"1998"},{"key":"10.1002\/jps.1055_bb0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1081\/PDT-100100557","article-title":"Permeability of chemical delivery systems across rabbit corneal (SIRC) cell line and isolated corneas: A comparative study","volume":"5","author":"Goskonda","year":"2000","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"10.1002\/jps.1055_bb0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jps.2600830338","article-title":"In vitro evaluation of a controlled-release site-specific diisovaleryl tert-butalone chemical delivery system for the eye","volume":"83","author":"Reddy","year":"1994","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.1055_bb0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/js980362t","article-title":"Permeability characteristics of novel mydriatic agents using an in vitro cell culture model that utilizes SIRC rabbit corneal cells","volume":"88","author":"Goskonda","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.1055_bb0050","unstructured":"Goskonda VR, Ghandehari H, Reddy IK. Novel site-specic chemical delivery systems as a potential mydriatic agent: Formation of phenyephrine in the irisciliary body from phenylephrone CDS. J Pharm Sci, in press."},{"key":"10.1002\/jps.1055_bb0055","series-title":"Advances in Drug Research","first-page":"255","article-title":"Novel approaches to the design of safer drugs: Soft drugs and site-specific chemical delivery systems","author":"Bodor","year":"1984"},{"key":"10.1002\/jps.1055_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1023\/A:1016348624897","article-title":"Improved delivery through biological membranes. XVII. A site-specific chemical delivery system as a short acting mydriatic agent","volume":"4","author":"Bodor","year":"1984","journal-title":"Pharm Res"},{"key":"10.1002\/jps.1055_bb0065","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0014-4835(84)90180-5","article-title":"Formation of adrenaline in the iris-ciliary body from adrenalone diesters","volume":"38","author":"Bodor","year":"1984","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1002\/jps.1055_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1081\/PDT-100101353","article-title":"Chemical delivery systems: Evaluation of physicochemical properties and enzymatic stability of phenylephrone derivatives","volume":"4","author":"Goskonda","year":"1999","journal-title":"Pharm Dev Technol"},{"key":"10.1002\/jps.1055_bb0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/jm00396a015","article-title":"Improved delivery through biological membranes 26. Design, systhesis, and pharmacological activity of a novel chemical delivery system for P-adrenergic blocking agents","volume":"31","author":"Bodor","year":"1988","journal-title":"J Med Chem"},{"key":"10.1002\/jps.1055_bb0080","series-title":"Trends in Medicinal Chemistry","first-page":"145","article-title":"Designing safer ophthalmic drugs","author":"Bodor","year":"1989"},{"issue":"2","key":"10.1002\/jps.1055_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1081\/DDC-100000480","article-title":"Intraocular pressure lowering activity and in vivo disposition of dipivaly terbutaline in rabbits","volume":"27","author":"Reddy","year":"2001","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.1055_bb0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0014-4835(78)90029-5","article-title":"Adrenergic drugs and intraocular pressure: Effects of selective beta-adrenergic agonists","volume":"27","author":"Potter","year":"1978","journal-title":"Exp Eye Res"},{"key":"10.1002\/jps.1055_bb0095","unstructured":"Reddy IK.1989.Rate controlled, site-specific chemical delivery systems for the treatment of glaucoma. Ph.D. Dissertation, University of Florida, Gainesville, Florida."},{"issue":"5","key":"10.1002\/jps.1055_bb0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1755-3768.1982.tb06733.x","article-title":"Enzyme activities and protein concentration in the intraocular fluids of ten mammals","volume":"60","author":"Wurster","year":"1982","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"12","key":"10.1002\/jps.1055_bb0105","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/096032719601501205","article-title":"Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro","volume":"15","author":"Kaliste-Korhonen","year":"1996","journal-title":"Hum Exp Toxicol"},{"key":"10.1002\/jps.1055_bb0110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/bi00830a024","article-title":"Steric effects in the acylation of a-chymotrypsin","volume":"8","author":"Milstein","year":"1969","journal-title":"Biochemistry"},{"key":"10.1002\/jps.1055_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-4835(74)90147-X","article-title":"Beta adrenergic responses in the eyes of rabbits, primates and man","volume":"19","author":"Langham","year":"1974","journal-title":"Exp Eye Res"},{"key":"10.1002\/jps.1055_bb0120","series-title":"Clinical Pharmacology of the Anterior Segment","first-page":"10","article-title":"Structures and fluids involved in the penetration of topically applied drugs","author":"Maurice","year":"1980"},{"key":"10.1002\/jps.1055_bb0125","first-page":"251","article-title":"A quantitative study on the relationship between transcorneal permeability of drugs and their hydrophobicity","volume":"24","author":"Kishida","year":"1980","journal-title":"Jpn J Ophthalmol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916307857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916307857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T15:50:46Z","timestamp":1557417046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916307857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0022354916307857"],"URL":"https:\/\/doi.org\/10.1002\/jps.1055","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}